SCHEMBL14475652

SCHEMBL14475652

CCOc1cc(-c2cccc(C)c2)cc2c(NC)nc(-c3cccnc3)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.48
▸ HSD17B10 Q99714 5/20 0.47
▸ CYP1A2 P05177 5/20 0.47
▸ CYP3A4 P08684 5/20 0.47
▸ CYP2D6 P10635 5/20 0.47
▸ CYP2C19 P33261 5/20 0.47
▸ CLK4 Q9HAZ1 3/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ MAPT P10636 6/20 0.45
▸ ALDH1A1 P00352 5/20 0.45
▸ KDM4E B2RXH2 5/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ TSHR P16473 3/20 0.45
▸ LMNA P02545 3/20 0.45
▸ MAPK1 P28482 3/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ USP2 O75604 2/20 0.45
▸ HIF1A Q16665 2/20 0.45
▸ CYP19A1 P11511 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16184859 0.92 HSD17B10 (0.52) GRM5HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL16184848 0.89 GRM5 (0.48) GRM5HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL16183623 0.89 CYP1A2 (0.49) HSD17B10CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL16184896 0.89 HSD17B10 (0.49) GRM5HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL16184849 0.89 MAPT (0.48) GRM5HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL16184853 0.87 HSD17B10 (0.47) GRM5HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL16184852 0.87 HSD17B10 (0.47) GRM5HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL16184856 0.87 CYP1A2 (0.48) GRM5HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL16184851 0.87 HSD17B10 (0.45) GRM5HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL16184861 0.86 S1PR1 (0.46) GRM5HSD17B10CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013003586-A1 QUINAZOLINES AS THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-03 — — WO disclosed
Send feedback